Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease - Concepedia

Concepedia

Publication | Closed Access

Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease

41

Citations

9

References

1996

Year

Anthony L. Zietman, K.C. Dallow, Patricia McManus, Niall M. Heney, William U. Shipley

UrologyProstate Cancer DeathProstate-specific Antigen FailureGenitourinary CancerMedicineClinical EndpointProstatic DiseaseOncologyRadiation OncologySurrogate Endpoint

References

	Year	Citations

Page 1